Physicians' Academy for Cardiovascular Education

Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction

3' education - Apr. 8, 2019 - Dr. Eri Kato, Kyoto, Japan

Educational information

This video was recorded at the Congress of the American College of Cardiology (ACC) 2019.

Faculty

Dr. Eri Kato is Cardiologist and researcher at the University of Kyoto in Japan.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Share this page with your colleagues and friends: